Safety and immunogenicity of tetanus/diphtheria vaccination in patients with rheumatic diseases-a prospective multi-centre cohort study

Bühler, Silja; Jaeger, Veronika Katharina; Adler, Sabine; Bannert, Bettina; Brümmerhoff, Carolin; Ciurea, Adrian; Distler, Oliver; Franz, Juliane; Gabay, Cem; Hagenbuch, Niels; Herzog, Christian; Hasler, Paul; Kling, Kerstin; Kyburz, Diego; Müller, Rüdiger; Nissen, Michaël; Siegrist, Claire-Anne; Villiger, Peter Matthias; Walker, Ulrich A; Hatz, Christoph

doi:10.1093/rheumatology/kez045

Scientific article

English

Safety and immunogenicity of tetanus/diphtheria vaccination in patients with rheumatic diseases-a prospective multi-centre cohort study

Published inRheumatology, vol. 58, no. 9, p. 1585-1596

Publication date2019

Abstract

We aimed to assess the safety and immunogenicity of a diphtheria/tetanus vaccine booster dose in three different patient groups with rheumatic diseases on a variety of immunosuppressive/immunomodulatory medications compared with healthy controls (HCs).

Keywords

Diphtheria vaccination
Immunogenicity
Immunosuppression
Rheumatic disease
Safety
Tetanus vaccination

Affiliation

Faculté de médecine / Section de médecine clinique / Département de médecine

Research group

Funding

Swiss National Science Foundation - Immunogenicity and safety of tetanus booster vaccine and hepatitis A vaccine in patients with rheumatoid arthritis, spondylarthritis and vasculitis - a cohort study in 6 Swiss rheumatology centres and 4 travel clinics [320030_143480]

Citation (ISO format)

BÜHLER, Silja et al. Safety and immunogenicity of tetanus/diphtheria vaccination in patients with rheumatic diseases-a prospective multi-centre cohort study. In: Rheumatology, 2019, vol. 58, n° 9, p. 1585–1596. doi: 10.1093/rheumatology/kez045

Article (Published version)

Identifiers

PID : unige:135497
DOI : 10.1093/rheumatology/kez045
PMID : 30877773

ISSN of the journal1462-0324

231views

0downloads

Creation12/05/2019 11:05:00 AM

First validation12/05/2019 11:05:00 AM

Update time03/15/2023 9:52:11 PM

Status update03/15/2023 9:52:10 PM

Last indexation01/17/2024 9:44:22 AM

Archive ouverte UNIGE

Safety and immunogenicity of tetanus/diphtheria vaccination in patients with rheumatic diseases-a prospective multi-centre cohort study

We aimed to assess the safety and immunogenicity of a diphtheria/tetanus vaccine booster dose in three different patient groups with rheumatic diseases on a variety of immunosuppressive/immunomodulatory medications compared with healthy controls (HCs).

Technical informations